Acute kidney injury (AKI) is common in patients with liver cirrhosis, occurring in 13-20% of patients hospitalized with decompensated cirrhosis, and is significantly associated with the prognosis. The development and progression of AKI is an independent predictive factor for mortality in these patients. If AKI develops, the renal function declines progressively even if AKI is improved later, the patients have a poorer prognosis compared to those who have not developed AKI. In addition, in patients without appropriate treatment or no improvement with the initial treatment, AKI often progress to hepatorenal syndrome (HRS), which is associated with significant morbidity and mortality. Therefore, early detection and appropriate management for the development of AKI is very important in these patients. Recently, there have been significant revisions in the diagnostic criteria and treatment of AKI and HRS; this manuscript reviews these changes. 
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The Korean Journal of Gastroenterology Major criteria 1) Chronic or actue liver disease with advanced hepatic failure and portal hypertension 2) Low glomerular filtration rate, as indicated by serum creatinine of >1.5 mg/dL or 24 hour creatinine clearance <40 mL/min 3) Absence of shock, ongoing bacterial infection, and current or recent treatment with nephrotoxic drugs, absence of gastrointestinal fluid losses (repeated vomiting or intense diarrhea) or renal fluid losses (weight loss >500 g/day for several days in patients with ascites without peripheral edema or 1,000 g/day in patiens with peripheral edema) 4) No sustained improvement in renal function (decrease in serum creatinine to 1.5 mg/dL or less or increase in creatinine clearance to 40 mL/min or more) following diuretic withdrawal and expansion of plasma volume with 1.5 L of isotonic sailine 5) Proteinuria <500 mg/day and no ultrasonographic evidence of obstructive uropathy or parenchymal renal disease Additional criteria 1) Urine volume <500 mL/day 2) Urine sodium <10 mEq/L 3) Urine osmolality greater than plasma osmolality 4) Urine red blood cells <50 per high-power field 5) Serum sodium concentration <130 mEq/L HRS, hepatorenal syndrome. 1) Cirrhosis with ascites 2) Serum creatinine >1.5 mg/dL 3) No improvement of serum creatinine (decrease to a level of 1.5 mg/dL) after at least 2 days with diuretic withdrawal and volume expansion with albumin; the recommended dose of albumin is 1 g/kg of body weight per day up to a maximum of 100 g/day 4) Absence of shock 5) No current or recent treatment with nephrotoxic drugs 6) Absence of parenchymal kidney disease as indicated by proteinuria >500 mg/day, microhematuria (>50 red blood cells per high-power field), and/or abnormal renal ultrasonography HRS, hepatorenal syndrome. 
